ICICI Prudential Nifty Pharma ETF
ICICI Prudential Mutual Fund · Equity ETF · exchange-traded fund
NAV (₹), 26 Oct 2026
25.7617
1-day change
n/a
1Y return
n/a
3Y CAGR
n/a
5Y CAGR
n/a
Max drawdown, 5Y
n/a
Returns vs Equity ETF median (258 schemes) and “Sector: Healthcare & pharma” median (9)
| Period | Scheme | Category median | Sector: Healthcare & pharma median |
|---|---|---|---|
| 1 month | n/a | -4.6% | -6.1% |
| 3 months | n/a | -5.4% | -3.6% |
| 6 months | n/a | -4.0% | 7.7% |
| Year to date | n/a | -8.4% | 7.3% |
| 1 year | n/a | -7.7% | 5.7% |
| 3 years (CAGR) | n/a | 9.3% | 20.0% |
| 5 years (CAGR) | n/a | 6.3% | 13.2% |
| 7 years (CAGR) | n/a | 11.3% | n/a |
| 10 years (CAGR) | n/a | 11.4% | n/a |
| Since first NAV (CAGR) | n/a | – | – |
“Sector: Healthcare & pharma” is MFIC's grouping of Equity ETF schemes by the theme or index in their names, not an AMFI category.
Rolling returns every business-day start date
| Measure | Scheme | Category median |
|---|---|---|
| 1Y rolling median | n/a | 9.1% |
| 3Y rolling median | n/a | 14.6% |
| 3Y rolling worst | n/a | 5.3% |
| 3Y periods positive | n/a | 100% |
| 3Y periods ahead of benchmark | n/a | n/a |
| 5Y rolling median | n/a | 14.4% |
| 5Y rolling worst | n/a | 5.4% |
| 5Y periods ahead of benchmark | n/a | n/a |
Benchmark: none available in MFIC's free data for this category.
Risk 36 months, monthly returns, Rf 6.5%
| Measure | Scheme | Category median |
|---|---|---|
| Standard deviation (ann.) | n/a | 16.8% |
| Sharpe ratio | n/a | 0.14 |
| Sortino ratio | n/a | 0.20 |
| Beta | n/a | n/a |
| Alpha (ann.) | n/a | n/a |
| Upside capture | n/a | n/a |
| Downside capture | n/a | n/a |
Drawdowns peak-to-trough falls in NAV
| Measure | Scheme | Category median |
|---|---|---|
| Maximum drawdown, full history | n/a | −21.0% |
| Maximum drawdown, last 10Y | n/a | −38.0% |
| Maximum drawdown, last 5Y | n/a | −20.6% |
| Current drawdown | n/a | −12.8% |
| Recovery time of worst fall | n/a | – |
Longer histories include more crises, so compare the 5Y and 10Y figures across schemes of different ages.
Fund managers and scheme facts Scheme Summary Document via AMFI
Objective: The objective of the investment scheme is to provide returns before expenses that closely correspond to the total return of the underlying index, subject to tracking errors. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.
Exit load: Entry Load nil. Exit Load: There will be no exit load for units sold through the secondary market on the stock exchanges where the Scheme will be listed. Currently, the Scheme is proposed to be listed on BSE and NSE. Investors shall note that the brokerage on sales of the units of the scheme on the stock exchanges shall be borne by the investors. However, during the process of creation/ redemption there may be transaction costs & /or other incidental expenses(forming part of the Cash Compon
Minimum application: ₹1,000
Allotment date: 12 Oct 2026
Documents: Scheme Information Document · Scheme Summary Document. Read the scheme documents before investing.
About ETF figures. All figures use the ETF's NAV as published by AMFI. Investors buy and sell ETFs on the stock exchange at the traded price, which can be above or below NAV and adds brokerage and bid-ask costs. Liquidity varies between ETFs.
Scheme facts
Category: Equity ETF
Plan / option: ETF · Growth
AMFI scheme code: 154804
ISIN: INF109K1A716
First NAV in MFIC data: 26 Oct 2026
History: 0.0 years
Portfolio holdings: see the scheme's monthly portfolio disclosure on the fund house website
Changes and data adjustments
- 26 Oct 2026: New scheme
Questions about ICICI Prudential Nifty Pharma ETF
- What is the latest NAV of ICICI Prudential Nifty Pharma ETF?
- The NAV of the ETF was ₹25.7617 on 26 Oct 2026, as published by AMFI.
- Which category is ICICI Prudential Nifty Pharma ETF in?
- It is classified as Equity ETF in AMFI's daily NAV file; a Equity ETF scheme tracks an equity index and trades on the stock exchange. MFIC compares it with 258 Equity ETF schemes (ETFs).
- What is the exit load of ICICI Prudential Nifty Pharma ETF?
- As stated in its scheme documents: Entry Load nil. Exit Load: There will be no exit load for units sold through the secondary market on the stock exchanges where the Scheme will be listed. Currently, the Scheme is proposed to be listed on BSE and NSE. Investors shall note that the brokerage on sales of the units of the scheme on the stock exchanges shall be borne by the investors. However, during the process of creation/ redemption there may be transaction costs & /or other incidental expenses(forming part of the Cash Compon Check the latest Scheme Information Document before investing, as loads can change.
- What is the minimum investment in ICICI Prudential Nifty Pharma ETF?
- The minimum application amount is ₹1,000.
Reviewing your own mutual fund portfolio?
Integrato's team can walk you through how your current schemes have behaved, using the same data shown here. Integrato is an AMFI-registered Mutual Fund Distributor.
Follow ICICI Prudential Nifty Pharma ETF by email
Every Monday: this scheme's NAV, 1-month and 1-year return beside its category median, 3-year CAGR and how far it is below its peak. Add more schemes from their pages or from your MFIC watchlist. Free; unsubscribe from any email.
Data & disclosure. Source: AMFI daily NAV file and historical NAVs via mfapi.in; calculations by MFIC, as of 26 Oct 2026. Category medians use ETFs in the same AMFI category. Mutual fund investments are subject to market risks; read all scheme-related documents carefully. Past performance may or may not be sustained in future. This page is for research and education only and is not investment advice or a recommendation to buy, sell or hold any scheme. Integrato Financial Services Pvt. Ltd. is an AMFI-registered Mutual Fund Distributor (ARN-173155). Methodology.